Literature DB >> 11979374

CD69 expression correlates with expression of other markers of Th1 T cell differentiation in peripheral T cell lymphomas.

David M Dorfman1, Aliakbar Shahsafaei.   

Abstract

CD69, a marker of early T cell activation, is associated with Th1 T cell differentiation. Previously we found that peripheral T cell lymphomas could be subdivided based on the expression of markers of Th1 versus Th2 differentiation, including CXCR3, CD134/OX40, CCR4, and CD30. Here we report immunohistochemical staining for CD69 in frozen and paraffin sections of peripheral T cell lymphomas that exhibit immunoreactivity for markers of Th1 or Th2 differentiation. CD69 expression correlated with immunoreactivity for other Th1 differentiation markers in 18 of 19 frozen specimens of peripheral T cell lymphomas (P = 0.0005). In 10 of these cases in which paraffin-embedded tissue was available for study, CD69 immunohistochemical staining of paraffin sections correlated with frozen section expression. CD69 immunostaining was performed on paraffin sections from 53 additional cases of peripheral T cell lymphoma and correlated with immunoreactivity for other Th1 differentiation markers (P < 0.0001) and was associated with specific subtypes of peripheral T cell lymphoma, including angioimmunoblastic lymphoma, Lennert's lymphoma, and mycosis fungoides/Sezary syndrome, previously noted to express Th1 differentiation-associated markers. Anaplastic large cell lymphoma, both systemic and cutaneous, which typically exhibits immunoreactivity for markers of Th2 expression, was negative for CD69 immunostaining in 22 of 24 cases. CD69 immunostaining results support previous findings that a subset of T cell lymphomas exhibits immunophenotypic features of either Th1 or Th2 T cell differentiation. In addition, CD69 is a useful immunohistochemical marker for specific T cell lymphomas in frozen and paraffin-embedded tissue. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11979374     DOI: 10.1053/hupa.2002.32215

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Uncommon late relapse of angioimmunoblastic T-cell lymphoma after 16-year remission period.

Authors:  Edit Páyer; Zsófia Miltényi; Zsófia Simon; Lajos Szabados; Katalin Hegyi; Gábor Méhes; Arpád Illés
Journal:  Pathol Oncol Res       Date:  2011-11-30       Impact factor: 3.201

2.  Loss of expression of the WNT/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas.

Authors:  David M Dorfman; Harvey A Greisman; Aliakbar Shahsafaei
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

3.  Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response.

Authors:  Vijayamahantesh Vijayamahantesh; Tapas Patra; Keith Meyer; Mohamad-Gabriel Alameh; Erin K Reagan; Drew Weissman; Ranjit Ray
Journal:  J Virol       Date:  2022-05-25       Impact factor: 6.549

4.  Myeloid STAT3 promotes formation of colitis-associated colorectal cancer in mice.

Authors:  Paulina Pathria; Dagmar Gotthardt; Michaela Prchal-Murphy; Eva-Maria Putz; Martin Holcmann; Michaela Schlederer; Beatrice Grabner; Ilija Crncec; Jasmin Svinka; Monica Musteanu; Thomas Hoffmann; Martin Filipits; Walter Berger; Valeria Poli; Lukas Kenner; Martin Bilban; Emilio Casanova; Mathias Müller; Birgit Strobl; Editha Bayer; Thomas Mohr; Veronika Sexl; Robert Eferl
Journal:  Oncoimmunology       Date:  2015-01-22       Impact factor: 8.110

5.  Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma.

Authors:  Takeya Adachi; Tetsuro Kobayashi; Eiji Sugihara; Taketo Yamada; Koichi Ikuta; Stefania Pittaluga; Hideyuki Saya; Masayuki Amagai; Keisuke Nagao
Journal:  Nat Med       Date:  2015-10-19       Impact factor: 53.440

6.  Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma.

Authors:  Matthias Farlik; Patrick M Brunner; Katharina Rindler; Constanze Jonak; Natalia Alkon; Felix M Thaler; Harald Kurz; Lisa E Shaw; Georg Stingl; Wolfgang Weninger; Florian Halbritter; Wolfgang M Bauer
Journal:  Mol Cancer       Date:  2021-09-28       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.